A number of firms have modified their ratings and price targets on shares of Clorox (NYSE: CLX) recently:
- 5/14/2023 – Clorox had its price target raised by analysts at Barclays PLC from $118.00 to $124.00.
- 5/4/2023 – Clorox had its price target raised by analysts at Barclays PLC from $113.00 to $118.00.
- 5/3/2023 – Clorox had its price target raised by analysts at Bank of America Co. from $130.00 to $140.00.
- 5/3/2023 – Clorox had its price target raised by analysts at Wells Fargo & Company from $145.00 to $150.00.
- 5/3/2023 – Clorox had its price target raised by analysts at UBS Group AG from $148.00 to $162.00.
- 5/3/2023 – Clorox had its price target raised by analysts at Raymond James from $165.00 to $185.00.
- 5/3/2023 – Clorox had its price target raised by analysts at Royal Bank of Canada from $137.00 to $151.00.
- 4/29/2023 – Clorox was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating.
- 4/21/2023 – Clorox was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating.
- 4/18/2023 – Clorox had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $147.00 to $149.00.
- 4/14/2023 – Clorox had its price target raised by analysts at Barclays PLC from $108.00 to $113.00. They now have an “underweight” rating on the stock.
- 4/12/2023 – Clorox had its price target raised by analysts at Wells Fargo & Company from $135.00 to $145.00. They now have an “underweight” rating on the stock.
- 4/6/2023 – Clorox had its price target raised by analysts at UBS Group AG from $140.00 to $148.00. They now have a “sell” rating on the stock.
- 3/20/2023 – Clorox had its price target lowered by analysts at Deutsche Bank Aktiengesellschaft from $152.00 to $147.00.
Clorox Stock Performance
Shares of Clorox stock opened at $166.98 on Thursday. The Clorox Company has a one year low of $120.50 and a one year high of $178.21. The company has a market cap of $20.64 billion, a PE ratio of 287.90, a P/E/G ratio of 3.02 and a beta of 0.30. The company has a debt-to-equity ratio of 14.40, a quick ratio of 0.51 and a current ratio of 0.87. The business has a 50-day simple moving average of $160.77 and a 200-day simple moving average of $151.74.
Clorox (NYSE:CLX – Get Rating) last announced its quarterly earnings data on Tuesday, May 2nd. The company reported $1.51 EPS for the quarter, topping analysts’ consensus estimates of $1.22 by $0.29. Clorox had a return on equity of 114.67% and a net margin of 1.03%. The business had revenue of $1.92 billion during the quarter, compared to the consensus estimate of $1.82 billion. During the same period in the previous year, the company posted $1.31 earnings per share. The business’s revenue for the quarter was up 5.9% on a year-over-year basis. On average, equities research analysts forecast that The Clorox Company will post 4.47 EPS for the current fiscal year.
Institutional Investors Weigh In On Clorox
The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States.
Recommended Stories
- Get a free copy of the StockNews.com research report on Clorox (CLX)
- 5 Best Bank ETFs to Buy Now
- How to Invest in Telehealth and Telemedicine Stocks
- Target’s Guidance Looms Over The MarketÂ
- Want Clean Energy? Siemens May Be Pointing To A Breakout
- Up Over 2,600% in 5 Years, Wall Street Still Calls Celsius a Buy
Receive News & Ratings for The Clorox Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Clorox Company and related companies with MarketBeat.com's FREE daily email newsletter.